Discovery of tissue-specific proteomic signatures in juvenile dermatomyositis highlights pathways reflecting persistent disease activity, clinical heterogeneity, and myositis-specific autoantibody subtype.

Neely J, Sabbagh SE, Dvergsten J, Madubata C, Berthier CC, Zheng Z, Goudsmit C, Matossian S, Ferris SP, Fragiadakis GK, Sirota M, Kahlenberg JM, Kim H, Turnier JL, CARRA Registry Investigators and CARRA Translational Medicine for Juvenile Myositis Working Group